Menten AI

United States
Saxeville, Wisconsin, United States, 94303

Company profile

Menten AI company profile

Menten AI designs new protein drugs and enzymes using quantum computers and machine learning. Proteins are large molecules that can twist into many shapes. Discovering the right shape for a protein to be a drug or a biocatalyst among almost endless possibilities is a major challenge. Menten AI solves this problem by using machine learning and quantum computing to find better starting points for discovery and further development. Quantum computing makes it possible to represent multiple states of the protein simultaneously and efficiently find the best designs. The team created the world’s first peptide designed on a quantum computer and is now working on peptide therapeutics for oncology and neurodegeneration, as well as on enzymes for industrial applications.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2018-08-24

Headquarters

Postal code
94303
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
Seed
Funding rounds
3
Total equity funding
$4M
Last funding
Seed / 2023-05-05
Last equity funding
Seed
Investors
9
Lead investors
3
Founders
3
Articles
13

Founders and investors

Founders

Hans MeloTamas GorbeVikram K. Mulligan

Lead investors

Alumni VenturesUncork CapitalY Combinator

Investors

Alumni Venturesbig_betsKhosla VenturesUncork CapitalY Combinator